Description
High Purity Dapagliflozin Propanediol Monohydrate Raw Powder CAS 960404-48-2 for Diabetes Treatment
Description
| Name: | Dapagliflozin Propanediol Monohydrate | Appearance: | Powder |
|---|---|---|---|
| Origin: | China | Cas: | 960404-48-2 |
| EINECS: | 204-752-2 | Storage: | -20°C |
| High Light: |
Dapagliflozin Propanediol Monohydrate Raw Powder, Dapagliflozin Propanediol Monohydrate 960404-48-2 |
||
High Purity Dapagliflozin Propanediol Monohydrate Raw Powder CAS 960404-48-2 for Diabetes Treatment
| Name | Dapagliflozin propanediol monohydrate |
| CAS | 960404-48-2 |
| MF | C24H35ClO9 |
| MW | 502.9823 |
What is dapagliflozin
Dapagliflozin is a prescription medication that is mainly used alongside diet and exercise to help treat type 2 diabetes, but it is also used in the treatment of heart failure. It was first approved by the US Food and Drug Administration (FDA) in 2014.Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This class of drug uses the kidneys to help control your glucose (blood sugar) levels. It works by increasing the amount of glucose removed from the body when you urinate. It also reduces the amount of effort your heart has to put in to pumping blood around your body.
What is dapagliflozin used for
- Dapagliflozin is a prescription medicine used:
- along with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes
- to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes who also have known cardiovascular disease or multiple cardiovascular risk factors
- to reduce the risk of cardiovascular death, hospitalization for heart failure in adult patients with heart failure, when the heart is weak and cannot pump enough blood to the rest of your body
- to reduce the risk of further worsening of your kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalization for heart failure in adults with chronic kidney disease.
- Dapagliflozin is not for people with type 1 diabetes. Dapagliflozin may increase the risk of diabetic ketoacidosis (increased ketones in your blood or urine) in people with type 1 diabetes.
- Dapagliflozin is not for use to improve blood sugar (glucose) control in adults with type 2 diabetes who have moderate to severe kidney problems, because it may not work.
- Dapagliflozin is not for people with certain genetic forms of polycystic kidney disease, or who are taking or have recently received immunosuppressive therapy to treat kidney disease. Dapagliflozin is not expected to work if you have these conditions.
- It is not known if dapagliflozin is safe and effective in children younger than 18 years of age.
Who should not take dapagliflozin
Do not take dapagliflozin if you:
- are allergic to dapagliflozin or any of the ingredients in dapagliflozin. See below for a list of ingredients in dapagliflozin. Symptoms of a serious allergic reaction to dapagliflozin may include:
- skin rash
- raised red patches on your skin (hives)
- swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowingIf you have any of these symptoms, stop taking dapagliflozin and contact your healthcare provider or go to the nearest hospital emergency room right away.
- are on dialysis.
Tag:
